Evidence of a breakdown of corticostriatal connections in Parkinson’s disease by Stephens, B., Mueller, A.J., Shering, A.F., Hood, S.H., Taggart, P., Arbuthnott, G.W., Bell, J.E., Kilford, L., Kingsbury, A.E., Daniel, S.E., Ingham, C.A.

Get full text

Deficits in a tricarboxylic acid cycle enzyme in brains from patients with Parkinson’s disease by Gibson, G.E, Kingsbury, A.E, Xu, H, Lindsay, J.G, Daniel, S, Foster, O.J.F, Lees, A.J, Blass, J.P

Get full text

Dopamine transporter (DAT) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease by Harrington, K.A., Augood, S.J., Kingsbury, A.E., Foster, O.J.F., Emson, P.C.

Get full text

NMDA NR1 subunit mRNA and glutamate NMDA-sensitive binding are differentially affected in the striatum and pre-frontal cortex of Parkinson’s disease patients by Meoni, P., Bunnemann, B.H., Kingsbury, A.E., Trist, D.G., Bowery, N.G.

Get full text

Glutamate decarboxylase-67 messenger RNA expression in normal human basal ganglia and in Parkinson's disease by Nisbet, A.P, Eve, D.J, Kingsbury, A.E, Daniel, S.E, Marsden, C.D, Lees, A.J, Foster, O.J.F

Get full text

How do people with knee osteoarthritis use osteoarthritis pain medications and does this change over time? Data from the Osteoarthritis Initiative by Kingsbury, Sarah R, Hensor, Elizabeth M A, Walsh, Ceara A E, Hochberg, Marc C, Conaghan, Philip G

Get full text

Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden by Cazier, J. -B., Rao, S. R., McLean, C. M., Walker, A. K., Wright, B. J., Jaeger, E. E. M., Kartsonaki, C., Marsden, L., Yau, C., Camps, C., Kaisaki, P., Taylor, J., Catto, J. W., Tomlinson, I. P. M., Kiltie, A. E., Hamdy, F. C.

Get full text